Arcturus Therapeutics Holdings

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARCT and other ETFs, options, and stocks.

About ARCT

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. 

CEO
Joseph E. Payne
CEOJoseph E. Payne
Employees
180
Employees180
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2013
Founded2013
Employees
180
Employees180

ARCT Key Statistics

Market cap
734.33M
Market cap734.33M
Price-Earnings ratio
-26.19
Price-Earnings ratio-26.19
Dividend yield
Dividend yield
Average volume
492.01K
Average volume492.01K
High today
$28.31
High today$28.31
Low today
$26.77
Low today$26.77
Open price
$27.64
Open price$27.64
Volume
671.64K
Volume671.64K
52 Week high
$43.81
52 Week high$43.81
52 Week low
$17.52
52 Week low$17.52

ARCT News

Yahoo Finance 5d
Analysts Estimate Arcturus Therapeutics to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Wall Street expects a year-over-year decline in earnings on lower revenues when Arcturus Therapeutics (ARCT) reports results for the quarter ended March 2024. W...

Analysts Estimate Arcturus Therapeutics to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
0%
Sell
10%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.